AlphaMark Advisors »

Akebia Therapeutics shares owned by AlphaMark Advisors

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by AlphaMark Advisors from 13F filings

Historical chart of AlphaMark Advisors investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by AlphaMark Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by AlphaMark Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $73k 39k 1.90

More positions owned by AlphaMark Advisors

iShares S&P 500 Etf (IVV)
Technology SPDR Etf (XLK)
Health Care SPDR (XLV)
SPDR Trust Unit SR Etf (SPY)
Procter & Gamble Company (PG)
Db-x Msci Eafe Currency-hedged (DBEF)
Sch Fnd Em Lg Etf schb fdt emk lg (FNDE)
Financial Select Sector SPDR (XLF)
First Tr Exchng Traded Fd Vi tcw opportunis (FIXD)
Industrial SPDR (XLI)
Select Sector Spdr Tr Communic etfeqty (XLC)
Janus Detroit Str Tr (JAAA)
Energy Select Sector SPDR (XLE)
Consumer Staples Select Sect. SPDR (XLP)
Regan Floating Rate Mbs (MBSF)

View all positions for AlphaMark Advisors

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics